<産業資料/調査レポートの題名> 2022年7月15日

女性健康診断の世界市場:用途別(出生前検査、ダウン症候群、不妊症検査、妊娠検査、尿路感染症、骨粗鬆症、乳房、子宮頸部、卵巣癌検査)、エンドユーザー別(病院、ホームケア)


◆英文タイトル:Global Women’s Health Diagnostics Market Size study, by Application (Prenatal Testing, Down Syndrome, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical, Ovarian Cancer Test), by End User (Hospitals, Home care) and Regional Forecasts 2019-2026

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Women’s Health Diagnostics Market, by Region, 2017-2026 (USD Billion)
1.2.2. Women’s Health Diagnostics Market, by Application, 2017-2026 (USD Billion)
1.2.3. Women’s Health Diagnostics Market, by End- User, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Women’s Health Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Women’s Health Diagnostics Market Dynamics
3.1. Women’s Health Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Women’s Health Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Women’s Health Diagnostics Market, by Application
5.1. Market Snapshot
5.2. Global Women’s Health Diagnostics Market by Application, Performance – Potential Analysis
5.3. Global Women’s Health Diagnostics Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
5.4. Women’s Health Diagnostics Market, Sub Segment Analysis
5.4.1. Prenatal Testing
5.4.2. Down Syndrome
5.4.3. Fertility Test
5.4.4. Pregnancy Test
5.4.5. Urinary Tract Infections
5.4.6. Osteoporosis
5.4.7. Breast cancer testing
5.4.8. Cervical cancer testing
5.4.9. Ovarian Cancer Test
Chapter 6. Global Women’s Health Diagnostics Market, by End -User
6.1. Market Snapshot
6.2. Global Women’s Health Diagnostics Market by End User, Performance – Potential Analysis
6.3. Global Women’s Health Diagnostics Market Estimates & Forecasts by End User 2016-2026 (USD Billion)
6.4. Women’s Health Diagnostics Market, Sub Segment Analysis
6.4.1. Hospital
6.4.2. Home care
Chapter 7. Global Women’s Health Diagnostics Market, Regional Analysis
7.1. Women’s Health Diagnostics Market, Regional Market Snapshot
7.2. North America Women’s Health Diagnostics Market
7.2.1. U.S. Women’s Health Diagnostics Market
7.2.1.1. Application breakdown estimates & forecasts, 2016-2026
7.2.1.2. End- User breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Women’s Health Diagnostics Market
7.3. Europe Women’s Health Diagnostics Market Snapshot
7.3.1. U.K. Women’s Health Diagnostics Market
7.3.2. Germany Women’s Health Diagnostics Market
7.3.3. Rest of Europe Women’s Health Diagnostics Market
7.4. Asia-Pacific Women’s Health Diagnostics Market Snapshot
7.4.1. China Women’s Health Diagnostics Market
7.4.2. India Women’s Health Diagnostics Market
7.4.3. Japan Women’s Health Diagnostics Market
7.4.4. Rest of Asia Pacific Women’s Health Diagnostics Market
7.5. Latin America Women’s Health Diagnostics Market Snapshot
7.5.1. Brazil Women’s Health Diagnostics Market
7.5.2. Mexico Women’s Health Diagnostics Market
7.6. Rest of The World Women’s Health Diagnostics Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Siemens AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Quest Diagnostics Inc.
8.2.3. Hologic, Inc.
8.2.4. F. Hoffmann-La Roche AG
8.2.5. Perkinelmer Inc.
8.2.6. Alere Inc.
8.2.7. GE Healthcare
8.2.8. Becton, Dickinson and Company
8.2.9. Abbott Laboratories
8.2.10. Biomérieux SA
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark